S 920 · 117th Congress 2021โ€“2023, ended

Affordable and Safe Prescription Drug Importation Act

Latest action · Mar 23, 2021 Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held. With printed Hearing: S.Hrg. 117-176.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 23, 2021
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Affordable and Safe Prescription Drug Importation Act

This bill allows expanded importation of eligible prescription drugs and addresses related issues.

Current law allows the Department of Health and Human Services (HHS) to authorize the importation of certain eligible prescription drugs from Canada if HHS certifies to Congress that doing so would pose no additional risk to public health and safety and would result in significant cost savings for consumers. The bill removes this certification requirement and requires HHS to issue regulations that permit the importation of qualifying prescription drugs from Canada. After a certain amount of time, HHS may authorize importation from certain other countries if it determines that importation from Canada has resulted in cost savings for consumers and increased access to safe medication.

The bill also expands the types of prescription drugs eligible for importation to include, for example, biologics such as insulin.

Furthermore, the bill allows individuals to use an eligible licensed foreign pharmacy to fill a U.S.-issued prescription for a qualifying drug for personal use. Currently, an individual seeking to import a prescription drug generally must acquire a waiver from HHS.

The bill imposes various requirements related to certification of foreign sellers, labeling of imported drugs, and supply chain security.

The bill also (1) prohibits certain acts that discriminate against foreign sellers, such as charging higher prices to foreign sellers than to other sellers in the same country; and (2) imposes criminal penalties for online websites that sell counterfeit drugs or dispense drugs without a required prescription.

Cosponsors 21

Members who signed on, in the order they did. All signed on Mar 23, 2021.

SeatCosponsorSigned on
D-CAAlex PadillaOriginalMar 23, 2021
D-MNAmy KlobucharOriginalMar 23, 2021
I-MEAngus S. King Jr.OriginalMar 23, 2021
D-MDChris Van HollenOriginalMar 23, 2021
D-NJCory A. BookerOriginalMar 23, 2021
D-MIDebbie StabenowOriginalMar 23, 2021
D-MAElizabeth WarrenOriginalMar 23, 2021
D-RIJack ReedOriginalMar 23, 2021
D-NHJeanne ShaheenOriginalMar 23, 2021
D-ORJeff MerkleyOriginalMar 23, 2021
D-WVJoe Manchin IIIOriginalMar 23, 2021
D-NYKirsten E. GillibrandOriginalMar 23, 2021
D-NMMartin HeinrichOriginalMar 23, 2021
D-VTPatrick J. LeahyOriginalMar 23, 2021
D-CTRichard BlumenthalOriginalMar 23, 2021
D-PARobert P. Casey Jr.OriginalMar 23, 2021
D-ORRon WydenOriginalMar 23, 2021
D-RISheldon WhitehouseOriginalMar 23, 2021
D-OHSherrod BrownOriginalMar 23, 2021
D-WITammy BaldwinOriginalMar 23, 2021
D-MNTina SmithOriginalMar 23, 2021

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateHealth, Education, Labor, and Pensions Committee
Referred Mar 23, 2021
Primary Health and Retirement Security Subcommittee
Hearings Mar 23, 2021

Actions 3

Everything that happened, newest first.

  1. Mar 23, 2021Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held. With printed Hearing: S.Hrg. 117-176.
  2. Mar 23, 2021Introduced in Senate
  3. Mar 23, 2021Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

ProductTitleKindPublished
R44832Frequently Asked Questions About Prescription Drug Pricing and PolicyReportMay 6, 2021

Related bills 3

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 97Affordable and Safe Prescription Drug Importation ActReintroduction ofJan 10, 2019
S 1898Affordable Medications ActRelated billMay 27, 2021
HR 2181Affordable and Safe Prescription Drug Importation ActIdentical billMar 24, 2021

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
Short Title(s) as Introduced
Affordable and Safe Prescription Drug Importation Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 23, 2021Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.